VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
50 hedge funds and large institutions have $48.8M invested in Viracta Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+11
Holders Change %
+28.21%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
14
Reduced
8
Closed
2
Calls
$689K
Puts
$155K
Net Calls
+$534K
Net Calls Change
-$36.8M